IR Searcher

年度	タイプ	日付	売上高	営業利益	経常利益	純利益
2023-03	新規	2022-05-12	20555	261	403	277
	修正	2022-11-09	23883(↑)	416(↑)	609(↑)	435(↑)
2024-03	新規	2023-05-11	24232	329	480	347
	修正	2024-02-06	22366(↓)	420(↑)	608(↑)	425(↑)
2025-03	新規	2024-05-13	22677	343	503	348
	修正	2024-11-08	23677(↑)	495(↑)	661(↑)	460(↑)

通期四半期別

　※来期予想のグラフはQ1と表記されているがQ4である。

通期四半期別

決算期	四半期	売上高	営業利益	経常利益	純利益	1株当たり純利益	営業利益率	経常利益率	売上高/前年比	営業利益/前年比	経常利益/前年比	純利益/前年比
予想		23677	495	661	460		2.09%	2.79%	4.8%	12.5%	1.5%	-6.4%
2025-03	2	12286	308	407	282	82.93	2.51%	3.31%	10.6%	30.8%	16.7%	14.5%
	1	5973	136	173	116	34.29	2.28%	2.9%	7.2%	38.7%	35.5%	36.7%
2024-03	4	22595	440	651	491	144.75	1.95%	2.88%	-7.9%	-9.8%	-3.2%	1.5%
	3	16954	376	507	355	104.76	2.22%	2.99%	-11%	-18.8%	-14.2%	-16.5%
	2	11113	236	349	246	72.59	2.12%	3.14%	-11.9%	-24%	-20%	-22.2%
	1	5571	98	128	85	25.16	1.76%	2.3%	-11.6%	-41.2%	-38.9%	-45.3%
2023-03	4	24529	488	673	484	141.83	1.99%	2.74%	16%	61.5%	41.8%	-16.3%
	3	19053	463	591	426	124.49	2.43%	3.1%	22.3%	101.5%	75.5%	88.9%
	2	12616	310	436	316	92.27	2.46%	3.46%	26.2%	190.9%	126.2%	154.9%
	1	6301	167	210	155	45.35	2.65%	3.33%	24.1%	490.7%	361.8%	621.3%
2022-03	4	21147	302	474	578	167.29	1.43%	2.24%	24.2%	91.8%	51.5%	143.4%
	3	15584	230	337	225	65.22	1.48%	2.16%	25.8%	77.9%	50.1%	50.4%
	2	9993	106	193	124	35.88	1.06%	1.93%	26.3%	98%	42.1%	37.3%
	1	5076	28	45	21	6.24	0.55%	0.89%	23.5%	-10.3%	-15.4%	-35.3%
2021-03	4	17032	157	313	237	68.47	0.92%	1.84%	-4%	23%	19.6%	-7.1%
	3	12388	129	224	150	43.19	1.04%	1.81%	-8.8%	3.8%	2.8%	-28.2%
	2	7911	53	135	90	26.05	0.67%	1.71%	-12.6%	-37.5%	-17.6%	-41.8%
	1	4110	31	53	33	9.61	0.75%	1.29%	-8.6%	8.2%	9.7%	8.3%
2020-03	4	17733	128	262	255	72.08	0.72%	1.48%	-11.8%	-53.2%	-36.3%	-6.2%
	3	13579	124	218	208	58.53	0.91%	1.61%	-12.8%	-47.7%	-34%	-5.5%
	2	9057	86	164	155	43.42	0.95%	1.81%	-12.3%	-42.1%	-29.9%	-2.1%
	1	4497	29	49	30	8.62	0.64%	1.09%	-16.4%	-65.5%	-57.2%	-60.6%
2019-03	4	20110	273	411	272	76.53	1.36%	2.04%	-0.4%	-18.2%	-8.9%	-13.2%
	3	15575	238	331	221	62.08	1.53%	2.13%	2.5%	-14.6%	-8.3%	-10.9%
	2	10328	149	235	158	133.78	1.44%	2.28%	4.9%	-14.2%	-3.1%	-6.6%

決算期	四半期	売上高	営業利益	経常利益	純利益	1株当たり純利益	営業利益率	経常利益率	売上高/前年比	営業利益/前年比	経常利益/前年比	純利益/前年比
予想	残	11391	187	254	178	―	―	―	―	―	―
2025-03	2	6313	172	234	166	48.64	2.72%	3.71%	13.91%	24.64%	5.88%	3.11%
	1	5973	136	173	116	34.29	2.28%	2.9%	7.2%	38.7%	35.5%	36.7%
2024-03	4	5641	64	144	136	39.99	1.13%	2.55%	3.01%	156%	75.61%	134.48%
	3	5841	140	158	109	32.17	2.4%	2.71%	-9.26%	-8.5%	1.94%	-0.91%
	2	5542	138	221	161	47.43	2.49%	3.99%	-12.24%	-3.5%	-2.21%	0%
	1	5571	98	128	85	25.16	1.76%	2.3%	-11.6%	-41.2%	-38.9%	-45.3%
2023-03	4	5476	25	82	58	17.34	0.46%	1.5%	-1.56%	-65.28%	-40.15%	-83.57%
	3	6437	153	155	110	32.22	2.38%	2.41%	15.13%	23.39%	7.64%	8.91%
	2	6315	143	226	161	46.92	2.26%	3.58%	28.43%	83.33%	52.7%	56.31%
	1	6301	167	210	155	45.35	2.65%	3.33%	24.1%	490.7%	361.8%	621.3%
2022-03	4	5563	72	137	353	102.07	1.29%	2.46%	19.79%	157.14%	53.93%	305.75%
	3	5591	124	144	101	29.34	2.22%	2.58%	24.88%	63.16%	61.8%	68.33%
	2	4917	78	148	103	29.64	1.59%	3.01%	29.36%	254.55%	80.49%	80.7%
	1	5076	28	45	21	6.24	0.55%	0.89%	23.5%	-10.3%	-15.4%	-35.3%
2021-03	4	4644	28	89	87	25.28	0.6%	1.92%	11.8%	600%	102.27%	85.11%
	3	4477	76	89	60	17.14	1.7%	1.99%	-1%	100%	64.81%	13.21%
	2	3801	22	82	57	16.44	0.58%	2.16%	-16.64%	-61.4%	-28.7%	-54.4%
	1	4110	31	53	33	9.61	0.75%	1.29%	-8.6%	8.2%	9.7%	8.3%
2020-03	4	4154	4	44	47	13.55	0.1%	1.06%	-8.4%	-88.57%	-45%	-7.84%
	3	4522	38	54	53	15.11	0.84%	1.19%	-13.82%	-57.3%	-43.75%	-15.87%
	2	4560	57	115	125	34.8	1.25%	2.52%	-7.82%	-12.31%	-4.96%	56.25%
	1	4497	29	49	30	8.62	0.64%	1.09%	-16.4%	-65.5%	-57.2%	-60.6%
2019-03	4	4535	35	80	51	14.45	0.77%	1.76%	-9.34%	-36.36%	-11.11%	-22.73%
	3	5247	89	96	63	-71.7	1.7%	1.83%	-1.91%	-16.04%	-19.33%	-20.25%
	2	4947	65	121	80	―	1.31%	2.45%	0.04%	-35.64%	-20.39%	-27.27%

3537 昭栄薬品 企業サイト Yahooファイナンス 日経新聞 株探 四季報

3537 昭栄薬品　企業サイト　　　Yahooファイナンス　日経新聞　株探　四季報